{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:00:09Z","timestamp":1791846009486,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T00:00:00Z","timestamp":1447459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00431-015-2662-x","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T23:12:18Z","timestamp":1447456338000},"page":"527-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis"],"prefix":"10.1007","volume":"175","author":[{"given":"Norman","family":"Junge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Tiedau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Verboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallensleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Schlue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imeke","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Doreen","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"2662_CR1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Buschenfelde KH M z, Zeniya M (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"2662_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S0004-28032006000100012","volume":"43","author":"MA Bellomo-Brandao","year":"2006","unstructured":"Bellomo-Brandao MA, Costa-Pinto EA, De Tommaso AM, Hessel G (2006) Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq Gastroenterol 43:45\u201349","journal-title":"Arq Gastroenterol"},{"key":"2662_CR3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","volume":"94","author":"PL Bittencourt","year":"1999","unstructured":"Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL, Laudanna AA, Kalil J (1999) Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 94:1906\u20131913","journal-title":"Am J Gastroenterol"},{"key":"2662_CR4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/gut.51.4.609","volume":"51","author":"PL Bittencourt","year":"2002","unstructured":"Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC (2002) Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha \u2212308 promoter polymorphism. Gut 51:609\u2013610","journal-title":"Gut"},{"key":"2662_CR5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","volume":"16","author":"CL Bowlus","year":"2010","unstructured":"Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C (2010) Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transpl 16:1324\u20131330","journal-title":"Liver Transpl"},{"key":"2662_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","volume":"51","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ (2009) Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol 51:161\u2013167","journal-title":"J Hepatol"},{"key":"2662_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ (2011) Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci 56:545\u2013554","journal-title":"Dig Dis Sci"},{"key":"2662_CR8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"Czaja AJ, Freese DK, American Association for the Study of Liver Disease","year":"2002","unstructured":"Czaja AJ, Freese DK, American Association for the Study of Liver Disease (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36:479\u2013497","journal-title":"Hepatology"},{"key":"2662_CR9","first-page":"2197","volume":"92","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Kruger M, Santrach PJ, Moore SB, Manns MP (1997) Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol 92:2197\u20132200","journal-title":"Am J Gastroenterol"},{"key":"2662_CR10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","volume":"45","author":"I Djilali-Saiah","year":"2006","unstructured":"Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F (2006) HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol 45:844\u2013850","journal-title":"J Hepatol"},{"key":"2662_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2002-35705","volume":"22","author":"PT Donaldson","year":"2002","unstructured":"Donaldson PT (2002) Genetics in autoimmune hepatitis. Semin Liver Dis 22:353\u2013364","journal-title":"Semin Liver Dis"},{"key":"2662_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/0891693021000054093","volume":"35","author":"PT Donaldson","year":"2002","unstructured":"Donaldson PT, Norris S (2002) Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35:555\u2013564","journal-title":"Autoimmunity"},{"key":"2662_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1399-0039.2010.01518.x","volume":"76","author":"HP Eberhard","year":"2010","unstructured":"Eberhard HP, Feldmann U, Bochtler W, Baier D, Rutt C, Schmidt AH, Muller CR (2010) Estimating unbiased haplotype frequencies from stem cell donor samples typed at heterogeneous resolutions: a practical study based on over 1 million German donors. Tissue Antigens 76:352\u2013361","journal-title":"Tissue Antigens"},{"key":"2662_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1824-7288-36-73","volume":"36","author":"AA Elfaramawy","year":"2010","unstructured":"Elfaramawy AA, Elhossiny RM, Abbas AA, Aziz HM (2010) HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection. Ital J Pediatr 36:73","journal-title":"Ital J Pediatr"},{"key":"2662_CR15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","volume":"33","author":"L Fainboim","year":"2001","unstructured":"Fainboim L, Canero Velasco MC, Marcos CY, Ciocca M, Roy A, Theiler G, Capucchio M, Nuncifora S, Sala L, Zelazko M (2001) Protracted, but not acute, hepatitis a virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology 33:1512\u20131517","journal-title":"Hepatology"},{"key":"2662_CR16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","volume":"41","author":"L Fainboim","year":"1994","unstructured":"Fainboim L, Marcos Y, Pando M, Capucchio M, Reyes GB, Galoppo C, Badia I, Remondino G, Ciocca M, Ramonet M (1994) Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immunol 41:146\u2013150","journal-title":"Hum Immunol"},{"key":"2662_CR17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G (2001) Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33:544\u2013553","journal-title":"Hepatology"},{"key":"2662_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25:541\u2013547","journal-title":"Hepatology"},{"key":"2662_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clinre.2014.03.015","volume":"38","author":"N Hadzic","year":"2014","unstructured":"Hadzic N, Hierro L (2014) Autoimmune liver disease: novelties in management. Clin Res Hepatol Gastroenterol 38:273\u2013276","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2662_CR20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696\u2013699","journal-title":"J Hepatol"},{"key":"2662_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","volume":"13","author":"R Liberal","year":"2014","unstructured":"Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D (2014) Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev 13:435\u2013440","journal-title":"Autoimmun Rev"},{"key":"2662_CR22","first-page":"53","volume":"55","author":"G Maggiore","year":"2009","unstructured":"Maggiore G, Riva S, Sciveres M (2009) Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. Minerva Gastroenterol Dietol 55:53\u201370","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2662_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","volume":"25","author":"G Mieli-Vergani","year":"2011","unstructured":"Mieli-Vergani G, Vergani D (2011) Autoimmune liver diseases in children\u2014what is different from adulthood? Best Pract Res Clin Gastroenterol 25:783\u2013795","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2662_CR24","doi-asserted-by":"crossref","unstructured":"Mieli-Vergani G, Vergani D (2013) Paediatric autoimmune liver disease. Arch Dis Child","DOI":"10.1136\/archdischild-2013-303848"},{"key":"2662_CR25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","volume":"46","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ (2007) Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 46:1138\u20131145","journal-title":"Hepatology"},{"key":"2662_CR26","first-page":"71","volume":"10","author":"DM Murasko","year":"1990","unstructured":"Murasko DM, Goonewardene IM (1990) T-cell function in aging: mechanisms of decline. Annu Rev Gerontol Geriatr 10:71\u201396","journal-title":"Annu Rev Gerontol Geriatr"},{"key":"2662_CR27","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/hep.26290","volume":"57","author":"JH Ngu","year":"2013","unstructured":"Ngu JH, Gearry RB, Frampton CM, Stedman CA (2013) Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study. Hepatology 57:2399\u20132406","journal-title":"Hepatology"},{"key":"2662_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2004.11.009","volume":"24","author":"R Oettinger","year":"2005","unstructured":"Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S (2005) Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. J Autoimmun 24:79\u201384","journal-title":"J Autoimmun"},{"key":"2662_CR29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","volume":"30","author":"M Pando","year":"1999","unstructured":"Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Canero-Velasco C, Fainboim L (1999) Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30:1374\u20131380","journal-title":"Hepatology"},{"key":"2662_CR30","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1478-3231.2011.02603.x","volume":"31","author":"EA Roberts","year":"2011","unstructured":"Roberts EA (2011) Autoimmune hepatitis from the paediatric perspective. Liver Int 31:1424\u20131431","journal-title":"Liver Int"},{"key":"2662_CR31","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/eji.1830221134","volume":"22","author":"R Schwab","year":"1992","unstructured":"Schwab R, Russo C, Weksler ME (1992) Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans. Eur J Immunol 22:2989\u20132993","journal-title":"Eur J Immunol"},{"key":"2662_CR32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","volume":"53","author":"A Spurkland","year":"1999","unstructured":"Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E (1999) HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:459\u2013469","journal-title":"Tissue Antigens"},{"key":"2662_CR33","volume":"9","author":"T Umemura","year":"2014","unstructured":"Umemura T, Katsuyama Y, Yoshizawa K, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M (2014) Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS One 9, e100565","journal-title":"PLoS One"},{"key":"2662_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(02)80564-5","volume":"36","author":"JA Underhill","year":"2002","unstructured":"Underhill JA, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D (2002) Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis. J Hepatol 36:156","journal-title":"J Hepatol"},{"key":"2662_CR35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1399-0039.2007.00919.x","volume":"70","author":"M Verboom","year":"2007","unstructured":"Verboom M, Hallensleben M, Horn PA, Blasczyk R (2007) Bioinformatic integration of biomechanics makes HLA sequencing universally applicable. Tissue Antigens 70:338\u2013339","journal-title":"Tissue Antigens"},{"key":"2662_CR36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MPG.0000000000000245","volume":"58","author":"P Wang","year":"2014","unstructured":"Wang P, Su H, Underhill J, Blackmore LJ, Longhi MS, Grammatikopoulos T, Okokon EV, Davies ET, Vergani D, Mieli-Vergani G, Ma Y (2014) Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives. J Pediatr Gastroenterol Nutr 58:457\u2013462","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2662_CR37","first-page":"1415","volume":"22","author":"M Wilschanski","year":"1995","unstructured":"Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L (1995) Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22:1415\u20131422","journal-title":"Hepatology"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-015-2662-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2662-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:32:09Z","timestamp":1559068329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-015-2662-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2662"],"URL":"https:\/\/doi.org\/10.1007\/s00431-015-2662-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]}}}